echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > COVID-19 vaccination strategy: when is one dose better than two?

    COVID-19 vaccination strategy: when is one dose better than two?

    • Last Update: 2021-11-02
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com


    Picture: The number of people vaccinated once (yellow) and twice (green) under the main priority and main promotion scenarios


    Image credit: Lucas Böttcher and Jan Nagler

    In many parts of the world, the supply of COVID-19 vaccine continues to lag behind demand


    In "Chaos" by "AIP Publishing", researchers from Frankfurt School of Finance and Management and University of California, Los Angeles explained the conditions under which the "first priority" vaccine campaign is most effective in preventing the spread of the COVID-19 virus


    The main first campaign is not to recommend that people get only one dose of the vaccine


    From an immunological point of view, the best stimulation program is always better


    Scientists simulated the spread of COVID-19 with a model of susceptibility, exposure, infection, recovery, and death


    Each compartment is further divided to consider unvaccinated, partially vaccinated, and fully vaccinated individuals


    Author Jan Nagler said: "We have a large degree of uncertainty about the parameters of COVID-19


    The research team found that the decline in vaccine usage was a key factor in this decision


    However, if the attenuation rate after a single injection is closer to the attenuation rate after two injections, the vaccine strategy will change


    The author of the study, Lucas B?ttcher, said: "Our results show that a better estimate of the rate of immune weakening is important for determining whether the primary priority program is more effective than the primary booster vaccine


    As the scientific community gathers more data on COVID-19 vaccination, scientists hope that this model will provide more information to public health experts and politicians who must decide to support or oppose a vaccination protocol


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.